↓ Skip to main content

A Randomized, Double-Blind, Double-Dummy Study of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Relative to Umeclidinium/Vilanterol Dry Powder Inhaler in COPD

Overview of attention for article published in Advances in Therapy, July 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

policy
1 policy source
twitter
3 X users

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
67 Mendeley
Title
A Randomized, Double-Blind, Double-Dummy Study of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Relative to Umeclidinium/Vilanterol Dry Powder Inhaler in COPD
Published in
Advances in Therapy, July 2019
DOI 10.1007/s12325-019-01015-3
Pubmed ID
Authors

François Maltais, Gary T. Ferguson, Gregory J. Feldman, Gaëtan Deslee, Arnaud Bourdin, Harald Fjällbrant, Agnieszka Siwek-Posłuszna, Martin A. Jenkins, Ubaldo J. Martin

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 67 100%

Demographic breakdown

Readers by professional status Count As %
Other 12 18%
Researcher 8 12%
Student > Bachelor 6 9%
Student > Master 5 7%
Student > Doctoral Student 3 4%
Other 5 7%
Unknown 28 42%
Readers by discipline Count As %
Medicine and Dentistry 19 28%
Pharmacology, Toxicology and Pharmaceutical Science 5 7%
Nursing and Health Professions 5 7%
Unspecified 2 3%
Agricultural and Biological Sciences 2 3%
Other 5 7%
Unknown 29 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 November 2021.
All research outputs
#6,075,316
of 22,919,505 outputs
Outputs from Advances in Therapy
#506
of 2,366 outputs
Outputs of similar age
#108,895
of 347,436 outputs
Outputs of similar age from Advances in Therapy
#15
of 56 outputs
Altmetric has tracked 22,919,505 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 2,366 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 347,436 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.